by DAVID.KIEWLICH | Sep 10, 2026 | Biotech Lab Access
Your data won’t care whether you had unrestricted access to lab equipment. But your ability to generate that data will. In 2026, raising seed and Series A funding is tough. Investors are asking for data. Sometimes even proof-of-concept data at seed stage. And in order...
by DAVID.KIEWLICH | Sep 4, 2026 | Biotech
Your startup can attract top talent with a dream, a promise, and a mission. However, retaining them? That’s another story. The Talent War Nobody Warned You About The Bay Area biotech job market is red hot. As of 2024, California’s life sciences sector has over 330,000...
by DAVID.KIEWLICH | Aug 21, 2026 | Biotech
Dr. David Kiewlich spent 18 months looking for lab space before he could conduct his first experiment as a founder. That’s 18 months of burn rate and no data. He had to go back to investors and ask for more money to get proof of concept data. His company needed...
by DAVID.KIEWLICH | Aug 14, 2026 | Biotech
So you’ve got the science down, the vision nailed, and the pitch deck perfected. But what’s stopping you from running your first experiment? It might just be one big, expensive hurdle: a lab. You need a full-on wet lab, complete with biosafety cabinets, CO2...
by DAVID.KIEWLICH | Aug 13, 2026 | Biotech
Biotech is the cutting edge of human advancement. Gene therapies are curing rare diseases. Cell-based immunotherapies are redefining oncology. Carbon-capturing biology and engineered materials are shaping climate change. The research has never been more exciting. Yet...